Shelton Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Shelton Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,700	Closed	-$8.03M	–	890
2017 Q1	$8.03M	Buy	+4,700	New	+$718K	0.56%	27
2016 Q4	–	Sell	-5,000	Closed	-$795K	–	896
2016 Q3	$795K	Buy	5,000 +4,950	+9,900%	+$763K	0.07%	249
2016 Q2	$739K	Sell	50 -4,950	-99%	-$731K	0.07%	265
2016 Q1	$708K	Buy	5,000 +2,000	+67%	+$268K	0.06%	268
2015 Q4	$426K	Sell	3,000 -3,200	-52%	-$427K	0.04%	406
2015 Q3	$758K	Hold	6,200	–	–	0.08%	224
2015 Q2	$805K	Hold	6,200	–	–	0.08%	226
2015 Q1	$833K	Buy	+6,200	New	+$799K	0.09%	226

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shelton Capital Management's TMO Position: Q1 2026 in Review

Shelton Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q1 2026, selling an estimated $1.39M and leaving 6,490 shares worth $3.19M. The position accounts for 0.07% of the portfolio, ranked #180.

Shelton Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.55M in Q3 2020. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Shelton Capital Management held 6,490 shares of Thermo Fisher Scientific worth $3.19M as of Q1 2026.
Shelton Capital Management sold 2,555 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.39M.
Thermo Fisher Scientific made up 0.07% of Shelton Capital Management's portfolio in Q1 2026, its #180 holding.
Shelton Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
Shelton Capital Management's Thermo Fisher Scientific position peaked at $5.55M in Q3 2020.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.